Show simple item record

Diseño de un protocolo de manejo para las alteraciones ejecutivas de los pacientes con cáncer de mama no metastásicos tratrados con quimioterapia.

dc.rights.licenseAtribución-NoComercial-SinDerivadas 2.5 Colombia (CC BY-NC-ND 2.5 CO)spa
dc.contributor.authorRayo Toro, Sandra Lilianaspa
dc.contributor.otherPardo, Frankspa
dc.date.accessioned2017-02-03T17:11:54Zspa
dc.date.accessioned2017-05-16T18:03:48Zspa
dc.date.available2017-02-03T17:11:54Zspa
dc.date.available2017-05-16T18:03:48Zspa
dc.date.created2015spa
dc.date.issued2015-06-19spa
dc.identifier.citationRayo Toro., S. L. (2015). Diseño de un protocolo de manejo para las alteraciones ejecutivas de los pacientes con cáncer de mama no metastásicos tratados con quimioterapia. [Tesis de Maestría]. Universidad Sergio Arboleda.spa
dc.identifier.urihttp://hdl.handle.net/11232/819eng
dc.description.abstractLa investigación se orientó al diseño de un Protocolo de Manejo, desde Enfermería, para las alteraciones en las funciones ejecutivas (atención, memoria, concentración) de pacientes con cáncer de mama no mestastático, tratados con quimioterapia, en un grupo de pacientes sobrevivientes del cáncer de mama. Se trata de una investigación de tipo descriptivo de corte trasversal, la recolección de datos se realizó en un instrumento diseñado para tal efecto, el análisis de la información se realizó aplicando distribuciones de frecuencias y la comparación se hizo mediante la relación de variables.spa
dc.format.extent97spa
dc.format.mediumDigitalspa
dc.format.mimetypeapplication/pdfeng
dc.language.isospaeng
dc.publisherUniversidad Sergio Arboledaspa
dc.rightshttps://repository.usergioarboleda.edu.co/bitstream/id/b886ceb0-9595-446d-9093-74a5f4f46f4c/license.txteng
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/2.5/co/eng
dc.titleDiseño de un protocolo de manejo para las alteraciones ejecutivas de los pacientes con cáncer de mama no metastásicos tratrados con quimioterapia.spa
dc.subject.lembEnfermos de cancer - Rehabilitaciónspa
dc.subject.lembCancer - Tratamientospa
dc.subject.lembEnfermos de cancerspa
dc.subject.lembSenos - Cancerspa
dc.subject.lembCancer - Quimioterapiaspa
dc.publisher.programMaestría en Docencia e Investigación Universitariaspa
dc.type.coarversionhttp://purl.org/coar/version/c_970fb48d4fbd8a85eng
dc.publisher.departmentEscuela de Postgradosspa
dc.relation.referencesAbraham, J., Aut., M.W., Moran, M.T. & Filburn. (2008). Adyuvant Chemotherapy for breast cáncer: effects on cerebral White matter seen in diffusion tensor imagins. Clinical Breast. Cancer, 8, 88-91.eng
dc.relation.referencesAhles, T.A. y Saykin A. J. (2007). Candidate mechanisms for chemotherapy-induced cognitive changes. Nature Cancer. 195-200.eng
dc.relation.referencesAhles, 2004 T.A. (2004). Do systemic cancer treatmen affect cognitive function? The Lancet Oncology, 5, 270-271.eng
dc.relation.referencesAhles, T. A. & Saykin, A. (2001). Cognitive effects of standard-dose chemotherapy in patients with cancer. Cancer Investigation, 19(8), 812-820.eng
dc.relation.referencesAhles, T.A. & Saykin A. J. (2002). Breast cáncer chemotherapy-related cognitive dysfunction. Clinical Breast Cancer, 3, 84-90.eng
dc.relation.referencesAhles, T. A. & Saykin, A. (2007). Candidate mechanisms for chemotherapy-induced cognitive changes. Nature Reviews Cancer, 7, 192-201.eng
dc.relation.referencesAhles; Mc Donald. (2010), longitudinal assement of cognitive changes associated with adjuvant treatment for breast cancer: Impact of age and cognitive reserve. Journal of Clinical Oncology, 4434-4440.eng
dc.relation.referencesÁlvarez & Rodríguez (2004). Variables asociadas al deterioro cognitivo en pacientes de cáncer de colon. Psicooncología, 300-324.spa
dc.relation.referencesAnderson-Hanley, Sherman, Riggs, Agocha (2003). Neuropsychological effects of treatments for adults with cancer: A meta-analysis and review of the literature. Journal of the international Neuropsychological Society, 967-975.eng
dc.relation.referencesBender, C.M. (2006). Chemotherapy may have small to moderate negative effects in cognitive functioning. Cancer Treatment Reviews, 32, 316-319eng
dc.relation.referencesBender, C.M., Sereika, S.M., Berga.S.L. & Vogel, (2006). Cognitive impairment associated with adjuvant therapy in breast cancer. Psycho-Oncology, 15, 422-430.eng
dc.relation.referencesBerglund, G. (1991). Late effectos of adjuvant chemotherapy and postoperative radiotherapy on quality of life among breast cancer patients. European Journal of Cancer. 1060-1075.eng
dc.relation.referencesBoykoff, Moieni & Subramanian, S.S. (2009). Confronting Chemobrain: an indepth look at survivors reports of impacto n work, social networks, ad health care response. Journal Cancer Survivors, 3, 223-232.eng
dc.relation.referencesCollins, B., Stewart, A. y Verma, S. (2009). Cognitive effects of chemotherapy on postmenopausal breast cancer patients year after treatment. Psycho-Oncology. 135- 145.eng
dc.relation.referencesCorrea, D.D y Ahles, T.A (2007). Late neuropsychologic effect of chemotherapy. Clinical Advences in Hematology & Oncology. 985-988.eng
dc.relation.referencesDepartamento Administrativo Nacional de Estadísticas (DANE) (2005), Censo población con cáncer.spa
dc.relation.referencesDietrich, J., Monje, M., Wefwl, J. & Meyers, C. (2008). Clinical patterns and biological correlates of cognitive dysfuncion associated with cancer therapy. The Oncologist, 13, 1285-1295.eng
dc.relation.referencesEberhardt, B. Dilger. S, y Miltner, N.H.R. (2006). Short-term monitoring of cognitive functions before and during the first course of treatment. Journal of Cancer Research and Clinical Oncology. 235-240.eng
dc.relation.referencesFalleti, M., Sanfilippo, A., Maruff, P., Weih, L. & Phillips K-A. (2005), the nature and severity of cognitive impairment associated with adjuvant chemotherapy in woman with breast cancer. A meta-analysis of the current literatura. Brain and Cognition. 59, 60-70.eng
dc.relation.referencesFardell, J.E., Vardy, J. & Logge, W. (2010). Single higj dose treatment with methotrexate causes long-lasting cognitive dysfunction in laboratoru rodents. Pharmacology, Bioschemistry and Behaviour, 97, 333-339.eng
dc.relation.referencesFeliú, J., López-Santiago, S., Martínez-Marín, V., Custodio, A.B & Cruzado, J.A. (2011). Bases biológicas del deterioro de la función cognitiva inducido por los tratamientos antineoplásicos. Psicooncología, 8, 201-213.spa
dc.relation.referencesFliessbach, K., Helmstaedter, C., Urbach, H., Althaus, A. & Pels, H (2005). Neuropsychological outcome after chemotherapy for primary CNS lymphoma. A prospective Study. Neurology, 64, 1184-1188.eng
dc.relation.referencesGardner, H (1993). Inteligencias Múltiples. La teoría en la práctica. México: Paidós.spa
dc.relation.referencesGómez, F. (2011). Déficit neuropsicológicos asociados a alteraciones cerebrales secundarias a tratamientos oncológicos. Psicooncología , 215-229.spa
dc.relation.referencesInagaki, M., Yoshikawa, E., Matsuoka, Y., Sugawara, Y., Nakano, T., Akechi T,, Wada N, Imoto, S., Murakami, K., & Uchitomi Y (2007). Smaller regional volumens of brain gray and White matter demonstrated in breast cancer survivors exposed to adjuvant chemotherapy. Cancer, 1, (109), 146-156.eng
dc.relation.referencesJacobsen, P.B., Garland, L.L. & Booth-Jones, M., (2004). Relationship of haemoglobin levels to fatigue and cognitiive functioning among cancer patients receiving chemotherapy. Journal of pain and symptom management, 28, 7-18.eng
dc.relation.referencesJansen, C. E., Miaskowski, C., Dodd, M., Dowling, G. & Kramer, J. A. (2005). A metaanalysis of studies of the effects of cancer chemotherapy on various domains of cognitive function. Cancer, 104, 2222-2233.eng
dc.relation.referencesJenkins, V., Shilling, V., Deustsch, G., Bloomfield, D., Morris, R., Allan, S. & Winstanley, J. (2006). A 3-year prospective study of the effects of adjuvant treatments on cognition in women with early stage breast cancer. British Journal of Cancer, 94, 828-834.eng
dc.relation.referencesKohli, S., Fisher, S.G., Tra, Y., Adams, M.J., Mapstone, M.G., Wesnes, K.A, et al (2009). The effect of modafinil on cognitivie function in breast cancer survivors [Abstract]. Cancer, 115, 2605-2616.eng
dc.relation.referencesJoshi, G., Sultana, R., Tangpong, J., Cole, M.P., D.,Vore M. et al, (2005). Free radical mediated oxidative stress and toxic side effects; in brain induced by the anticancer drug adriamycin: insight into chemobrain. Free Radical Research, 1147-1155.eng
dc.relation.referencesLeón-Carrión J.L. (1995). Manual de neuropsicología humana. Madrid: Siglo XXI.spa
dc.relation.referencesLee, G.D., y Longo, D.L. (2006). Cancer chemotherapy and cognitive function in rodent models: memory impairment induced by cyclofosphamide in mice. Clínical Cáncer Research, 12, 5000-50001.eng
dc.relation.referencesLópez-Santiago., S., Cruzado, J.A. & Feliú, J. (2009). Chemobrain. Revisión de estudios que evalúan el deterioro cognitivo de supervivientes de cáncer de colon previamente a recibir tratamiento de quimioterapia. Psicooncología, 6, 121-137.spa
dc.relation.referencesLópez-Santiago, S., Cruzado, J.A. & Feliú. J (2011). Cremobrain. Revisión de estudios que evalúa el deterioro cognitivo de supervivientes de cáncer tratados con quimioterapia. Psicooncología, 8, 265-280.spa
dc.relation.referencesMcAllister, Ahles, T.A., Saykin, A. J., et al. (2004). Cognitive effects of cytotoxic cancer chemotherapy: predisposing risk factors and potential treatment. Current Psichiatry Reports. 360-370.eng
dc.relation.referencesMartínez Arias, M.R., Portellano Pérez, J.A., Castel Barba, S., García Pacios, J. & Melero Carrasco, H. (2009). El test de la anillas (TA). Un nuevo instrumento para la evaluación neuropsicológica de las funciones ejecutivas en adultos Polibea, 1(92), 10-12spa
dc.relation.referencesMateos-Beato, F. Y de las Heras, S.R (2002). Complicaciones neurológicas del cáncer sistémico y de su tratamiento. Revista de Neurología. 285-290.spa
dc.relation.referencesMehnert, A., Scherwath, A., Schirmer, L., Schleimer, B., Petersen. C. & SchulzKindermann, F. (2007). The association between neuropsychological impairment, self-perceived, cognitive deficits, fatigue and heath related quality of life in breast cancer survivors following standard adyuvant vs. High-dose chemotherapy. Patient Education and Counseling, 66, 108-118.eng
dc.relation.referencesMeyers & Hess, K.S. (2003). Multifaceted ends in brain tumour clinical trials: cognitive deteriotation precedes MRI progression. Neuro-Oncology. 5, 89-97.eng
dc.relation.referencesO´Shaughessy, J.A. (2002). Effects of epotin alfa on cognitive function, moodm astenia, and quality of life in women with breast cáncer undergoing adjuvant chemotherapy. Clinical Breast Cancer, (supplemetn), 3, 116-120.eng
dc.relation.referencesPeña-Casanova, J. (1991). Normalidad, semiología y patología neuropsicológcas: programa integrado de exploración neuropsicológica “Test Bacelona”. Barcelona.spa
dc.relation.referencesRubio B., Sirgo, A., Forcadell, E., Mele, M., & Gumà J. (2009). Deterioro cognitivo por los tratamientos oncológicos sistémicos en el cáncer de mama no metastásico: Revisión de estudios. Psicooncología.6, 83-120spa
dc.relation.referencesScheibel, R.S., Valentine, A.D., O´Brien, S. & Meyers, C.A. (2004). Cognitive dysfuntion and depression during treatment wiyh interferón-alpha and chemotherapy. Journal of Neuropsychiartry and Clinical Neurosciencies, 16, 185-191.eng
dc.relation.referencesShilling, V., Jenkins, V., Morris, R., Deutsch, G. & Bloomfield, D. (2005). The effects of adjuvant chemotherapy on cognition in woman with breast cancer-perliminary results of an observational longitudinal study. The Breat, 15, 142-150.eng
dc.relation.referencesShillamy, N. (1996). Larousse Diccionario de Psicología. Barcelona: Larousse Planeta. Sternberg, R. (1999). Inteligence as developing expertise. Contemporary Educational Psychology. 24, 359-375eng
dc.relation.referencesTangpong, Cole, M.P, Estus, S. (2007). Chemobrain: is systemic chemotherapy neurotoxic. Current Opinion in Oncology, 624-632.eng
dc.relation.referencesTannock, I.F., Ahles, T.A, Ganz, P.A. & Van Dam F.S (2004). Cognitive impairment associated with chemotherapy for cancer: Report of a Workshop. Journal of Clinical Oncology, 22, 2233-2239.eng
dc.relation.referencesVardy, J. (2008). Neurocognitive effects of chemotherapy in adults. Australian Prescriber, 31, 22-24.eng
dc.relation.referencesVardy, J. (2009). Cognitive function in survivors of cancer. American Society of Clinical Oncology Educational, 1, 570-574.eng
dc.relation.referencesWefel, J.S., Lenzi, R., Theriaut, R., Buzdar, A.U., Cruickshank, S. & Meyers, C.A. (2004). Chemobrain in breast carcinoma: A prologue. Cancer, 101, 466-475.eng
dc.rights.coarhttp://purl.org/coar/access_right/c_abf2eng
dc.identifier.instnameinstname:Universidad Sergio Arboledaeng
dc.identifier.reponamereponame:Repositorio Institucional Universidad Sergio Arboledaeng
dc.identifier.repourlrepourl:https://repository.usergioarboleda.edu.co/eng
dc.type.coarhttp://purl.org/coar/resource_type/c_bdcceng
dc.type.localTesis/Trabajo de grado - Monografía – Maestríaspa
dc.subject.proposalalteraciones ejecutivasspa
dc.subject.proposalcáncer de mamaspa
dc.subject.proposalquimioterapiaspa
dc.description.degreenameMagister en Docencia e Investigación Universitariaspa
dc.description.degreelevelMaestríaspa


Files in this item

Thumbnail
Name:
Diseño de un protocolo de manejo ...
Size:
3.209Mb
Format:
PDF
View/Open

This item appears in the following Collection(s)

Show simple item record

Atribución-NoComercial-SinDerivadas 2.5 Colombia (CC BY-NC-ND 2.5 CO)
Except where otherwise noted, this item's license is described as Atribución-NoComercial-SinDerivadas 2.5 Colombia (CC BY-NC-ND 2.5 CO)